
LathMized NAD+ Load Up (7-Day Dose)
LathMized NAD+
Stabilized NAD+ Compound
LathMized NAD+ Load Up is a high-potency, 7-day intensive oral powder formulated with intraMITOcell's proprietary LathMized stabilization technology. Unlike conventional NAD+ supplements that degrade in as little as 5 days at room temperature, LNAD+ is specifically stabilized both outside and inside the body, ensuring the molecule remains bioactive where it matters most. In clinical studies, LNAD+ increased intracellular NAD+ levels by 53% within 5 days and produced a 25% increase in NAD+ levels within just 4 hours in the spinal cord — outcomes no other oral NAD+ product has demonstrated. This intensive protocol is designed for individuals seeking rapid NAD+ restoration, including those managing neurological conditions, chronic fatigue, or age-related NAD+ decline. Up to 90% more affordable than clinic-based IV NAD+ infusions without sacrificing effectiveness.
Indications
Rapid NAD+ restoration, cellular energy optimization, neurological support, fatigue reduction, inflammation management, age-related NAD+ decline, adjunct for MS, cerebral palsy, and Lyme disease support
- — 53% increase in intracellular NAD+ levels within 5 days
- — 25% increase in spinal cord NAD+ within 4 hours
- — Proprietary LathMized stabilization — effective inside and outside the body
- — Up to 90% more affordable than IV NAD+ infusions
- — Supports neurological health, mobility, and cognition
- — Promotes sleep quality and overall quality of life
- — No injection required — oral powder format
Price
$1,995
Medication Details
7-day supply
Concentration: ~2,143 mg/day
Dosing
Daily for 7 days
Administration
Oral (Powder)
Storage & Handling
Refrigerate after reconstitution (36°F–46°F / 2°C–8°C). Do not freeze. Protect from light. Discard after 90 days.
Notes
15,000 mg total over 7-day intensive protocol. Mix powder as directed. Store at room temperature in sealed packaging — LathMized stabilization prevents degradation. Consult provider for individualized dosing and follow-up maintenance protocol.
Consult your prescribing Healthcare Provider for dosing adjustments.
Disclaimer
This medication is compounded and provided for use only under the supervision of a licensed healthcare provider. Use only as prescribed. Individual results may vary.
Version 2.2 | Effective Date: January 31, 2026




